COM:ZEVRA
Zevra Therapeutics
- Stock
Last Close
7.99
14/02 21:00
Market Cap
235.22M
Beta: -
Volume Today
340.99K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 12.84M - | 13.29M 3.50% | 28.65M 115.61% | 10.46M 63.50% | 27.46M 162.58% | ||||||
cost of revenue | 2.94M - | 1.30M 55.69% | 2.06M 57.78% | 343K 83.34% | 2.94M 758.60% | ||||||
gross profit | 9.89M - | 11.98M 21.11% | 26.59M 121.91% | 10.12M 61.96% | 24.52M 142.37% | ||||||
selling and marketing expenses | |||||||||||
general and administrative expenses | 8.88M - | 14M 57.60% | 12.77M 8.76% | 12.51M 2.07% | 10.82M 13.53% | 7.92M 26.77% | 8.70M 9.85% | 15.34M 76.34% | |||
selling general and administrative expenses | 4.53M - | 8.88M 96.26% | 14M 57.60% | 12.77M 8.76% | 12.51M 2.07% | 10.82M 13.53% | 7.92M 26.77% | 8.70M 9.85% | 15.34M 76.34% | 34.31M 123.65% | |
research and development expenses | 11.92M - | 13.93M 16.90% | 20.47M 46.95% | 20.59M 0.59% | 41.76M 102.78% | 19.41M 53.51% | 8.84M 54.45% | 10.16M 14.90% | 19.61M 93.03% | 39.81M 102.95% | |
other expenses | -31.82M - | ||||||||||
cost and expenses | 16.44M - | 22.81M 38.74% | 34.47M 51.10% | 33.37M 3.21% | 54.27M 62.64% | 33.18M 38.87% | 18.07M 45.54% | 20.92M 15.78% | 35.30M 68.73% | 77.06M 118.31% | |
operating expenses | 16.44M - | 22.81M 38.74% | 34.47M 51.10% | 33.37M 3.21% | 54.27M 62.64% | 30.23M 44.29% | 16.76M 44.55% | 18.86M 12.51% | 34.96M 85.33% | 74.12M 112.03% | |
interest expense | 2.72M - | 2.67M 1.63% | 7.13M 166.83% | 7.34M 2.95% | 7.09M 3.41% | 6.51M 8.09% | 7.09M 8.84% | 376K 94.70% | 335K 10.90% | 1.50M 348.06% | |
ebitda | -16.36M - | -22.81M 39.41% | -34.12M 49.55% | -32.66M 4.26% | -53.52M 63.85% | -20.03M 62.58% | -4.69M 76.57% | 7.98M 270.01% | -24.08M 401.89% | -49.60M 105.98% | |
operating income | -16.44M - | -22.81M 38.74% | -37.48M 64.29% | -33.37M 10.98% | -55.90M 67.54% | -20.34M 63.62% | -4.78M 76.49% | 7.73M 261.66% | -24.84M 421.41% | -49.60M 99.68% | |
depreciation and amortization | 74.76K - | 84K 12.36% | 175K 108.33% | 336K 92% | 324K 3.57% | 309K 4.63% | 89K 71.20% | 248K 178.65% | 760K 206.45% | ||
total other income expenses net | -5.32M - | -31.82M 497.90% | 24.71M 177.66% | -3.09M 112.51% | 4.34M 240.47% | -4.21M 196.89% | -8.01M 90.47% | -16.25M 102.80% | -17.49M 7.61% | 3.56M 120.33% | |
income before tax | -24.48M - | -54.64M 123.22% | -16.53M 69.74% | -43.43M 162.71% | -56.59M 30.31% | -24.54M 56.63% | -12.79M 47.87% | -8.52M 33.40% | -42.33M 396.76% | -46.05M 8.79% | |
income tax expense | -22.25K - | 26K 216.87% | -15K 157.69% | -43K 186.67% | -126K 193.02% | -22K 82.54% | -34K 54.55% | 34K 200% | -786K 2,411.76% | ||
net income | -24.45M - | -54.66M 123.53% | -16.52M 69.79% | -43.39M 162.69% | -56.47M 30.15% | -24.52M 56.57% | -12.76M 47.97% | -8.55M 32.95% | -41.54M 385.60% | -46.05M 10.85% | |
weighted average shs out | 769.24K - | 460.54K 40.13% | 912.32K 98.10% | 915.81K 0.38% | 1.12M 22.36% | 1.85M 65.39% | 3.98M 114.79% | 29.77M 647.71% | 34.49M 15.87% | 35.45M 2.79% | |
weighted average shs out dil | 769.24K - | 460.54K 40.13% | 912.32K 98.10% | 915.81K 0.38% | 1.12M 22.36% | 1.85M 65.39% | 3.98M 114.79% | 29.77M 647.71% | 34.49M 15.87% | 35.45M 2.79% | |
eps | -31.79 - | -118.69 273.36% | -18.10 84.75% | -47.37 161.71% | -50.39 6.38% | -13.23 73.74% | -3.21 75.74% | -0.29 90.97% | -1.20 313.79% | -1.30 8.33% | |
epsdiluted | -31.79 - | -118.69 273.36% | -18.10 84.75% | -47.37 161.71% | -50.39 6.38% | -13.23 73.74% | -3.21 75.74% | -0.29 90.97% | -1.20 313.79% | -1.30 8.33% |
All numbers in USD (except ratios and percentages)